Fredun Pharmaceuticals Ltd (FPL) has acquired pet-wellness brand Furlicks from pharmaceutical company USV and its subsidiary Wellbeing Nutrition, marking FPL’s entry into the pet-wellness market. The company announced the acquisition on September 8, 2026.
Furlicks develops pet supplements in oral-strip formats designed to provide an alternative to conventional supplement forms. Its existing portfolio covers skin and coat, gut health, joint care, calming, oral care and multivitamins.
FPL plans to use its existing manufacturing, product development, quality, research and development, supply-chain and distribution capabilities to expand the brand. Its immediate plan includes 12 new SKUs in the first phase, followed by 32 additional SKUs in the second phase. The company said it aims to develop Furlicks from an oral-strip proposition into a broader everyday pet-wellness platform.
Speaking on the acquisition, Mr. Fredun Medhora, MD & CFO, Fredun Pharmaceuticals Ltd. stated, “Furlicks marks a bold new chapter in FPL’s journey into pet wellness. We see Furlicks as more than an addition to our portfolio- it is a differentiated platform with the potential to build a significant pet-wellness business.” He further added that by combining the two brands’ expertise, we aim to make quality pet care more accessible to millions of pet parents across India. Our focus is to scale Furlicks while retaining its focus on innovation, simplicity and understanding of pet owners.
The acquisition comes as FPL seeks to combine its pharmaceutical and manufacturing capabilities with Furlicks’ existing pet-wellness portfolio and consumer positioning.
